13 April 2017

NorthEdge achieves 2.5x return on Fine Industries sale

NorthEdge Capital has completed the sale of its chemicals’ manufacturer Fine Industries Limited to Chinese-listed life sciences company Lianhe Chemical Technology Company Limited (Lianhetech).

The transaction is NorthEdge’s fourth exit following the sale of Sumo Digital and IPOs of Accrol Group Holdings and Ramsdens Financial, and represents a 2.5x return on investment for NorthEdge Capital Fund I.

Shenzhen-listed Lianhetech is China’s leading chemical contract manufacturer, with a market cap of approx. USD 2bn and revenues in excess of USD 600m across seven chemical production sites, two machinery production sites and two R&D centres in China.

Based in Middlesbrough, Fine Industries will become Lianhetech’s European base, allowing the organisation to operate in closer proximity to its customers and markets in Crop Protection, Pharma and Performance Chemicals. The transaction also extends the business’ portfolio of product development services and manufacturing solutions.

With around 220 employees, Fine Industries is a leading contract manufacturer of high-quality products and solutions used in the chemical and life sciences industries. The company develops and manufactures complex intermediates and actives for its agrochemical and pharma clients, as well as a broad portfolio of solutions for the chemicals market. The firm delivered a turnover of £52m and an EBITDA of £10m in the year to September 2016.

NorthEdge originally invested in Fine Industries in November 2013. The investment was led by Partner and Head of New Business Ray Stenton, assisted by Investment Director Tom Rowley and has been managed by Ray, Portfolio Director Ben Wildsmith and Investment Manager George Potts. NorthEdge operates from offices in Birmingham, Leeds and Manchester with £540m of funds under management, and is currently investing from NorthEdge Capital Fund II which closed in March 2016.

Ray Stenton, Partner and Head of New Business at NorthEdge Capital, said: “This deal represents a fantastic return on investment for NorthEdge Capital Fund I. It is pleasing to see our portfolio companies be recognised internationally, and it is testament to the strong progress Fine Industries has made in the years since our investment that it has attracted interest from Lianhetech – a key player in the chemicals sector.”

Maggie Wang Board Chairwoman and CEO at Lianhetech, said: “The acquisition provides the geographic presence, capability and expertise needed to develop new products and better utilise Lianhetech’s state-of-the-art technologies for our customers around the world. I am delighted to welcome the Fine Industries Group, its employees, expertise and capabilities into our company. Together we will strengthen our technical solutions and product offerings to our global customer base.”

Contact our press offices at MC2 for more information. northedge@thisismc2.com 0161 236 1352

Follow us on LinkedIn